Elsevier

The Lancet

Volume 378, Issue 9793, 27 August–2 September 2011, Pages 746-747
The Lancet

Comment
Where next for obesity?

https://doi.org/10.1016/S0140-6736(11)61272-5Get rights and content

References (8)

There are more references available in the full text version of this article.

Cited by (39)

  • Excess calorie availability and adult BMI: A cohort analysis of patterns and trends for 156 countries from 1890 to 2015

    2022, Food Policy
    Citation Excerpt :

    The ratio of overweight to underweight individuals is increasing globally in step with improvements in per capita incomes (Abarca-Gómez et al., 2017; Abdullah, 2015; Barrera, 2018; Barrera and Hertel, 2022). Further, the double burden associated with the simultaneous presentation of poor nutrition, both at low and high levels of calorie consumption, continues to increase in the poorest low-income and middle-income countries (Popkin et al., 2020; Rutter, 2011; Siddiqui and Donato, 2020). In 2016, 41 million children under five years of age were overweight, and in the same year the Food and Agriculture Organization of the United Nations (FAO) estimated 3.4 million deaths annually due to overweight and obesity (FAO, 2017a).

  • The combined used of quantitative and qualitative longitudinal methods in the study of obesity

    2021, Gaceta Sanitaria
    Citation Excerpt :

    The alarming increase in the prevalence of obesity worldwide has led to substantial academic and policy interest and action.1–4 Obesity is a complex phenomenon with many determinants in both the social and biological realms that are likely to act independently, in series, and synergistically in both predictable and unpredictable ways.1,5–8 The importance of both biological and social factors in the etiology of obesity has led to many calls for inter-, multi- and even transdisciplinary working between those with training in the social and natural sciences, and beyond, in order to achieve a comprehensive understanding of both the ‘problem’, and potential solutions.8–11

  • Chemical composition and in vitro antiobesity and in vivo anti-hyperlipidemic effects of Ceratotheca sesamoides, Jatropha tanjorensis, Mucuna flagellipes, Pterocarpus mildbraedii and Piper guineense

    2021, Phytomedicine Plus
    Citation Excerpt :

    The worldwide prevalence of obesity has since been on the increase (Garvey et al., 2016), and as at 2016, about 13% of the world's adult population were obese (WHO, 2020). Obesity has now become one of the leading causes of death around the world (Jones et al., 2012), and has comorbidities such as insulin resistance, diabetes, hyperlipidemia, hypertension, heart attacks, stroke, osteoarthritis and some cancers (Martorell et al., 2000; Rutter, 2011). The prevention of obesity is better than management/treatment which usually involves the use of drugs coupled with dieting and increased physical activity.

  • Pleasure: An under-utilised ‘P’ in social marketing for healthy eating

    2016, Appetite
    Citation Excerpt :

    The rapid trajectory of obesity prevalence has been attributed to numerous causes, including the built environment, sedentary lifestyles, excessive screen time, genetics, ubiquitous food marketing, a trend towards greater food consumption outside of the home, and sleep deprivation (Burns, Jackson, Gibbons, & Stoney, 2002; Chahal, Fung, Kuhle, & Veugelers, 2013; Lichtenstein et al., 2006; Maher, Olds, Eisenmann, & Dollman, 2012; Morrill & Chinn, 2004; Zimmerman, 2011). This diverse range of causal factors points to the need for comprehensive programmatic approaches that include micro-, meso-, and macro-level components to cater for the complex aetiology of the condition (Gortmaker et al., 2011; Rutter, 2011). Once established, obesity is difficult to treat, making prevention the preferred approach.

View all citing articles on Scopus
View full text